These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 2650285)

  • 1. Immunosuppression by cyclosporine in vivo need not block effector T-cell function in mice.
    Auchincloss H
    Transplant Proc; 1989 Feb; 21(1 Pt 1):860. PubMed ID: 2650285
    [No Abstract]   [Full Text] [Related]  

  • 2. Immunosuppression induced by monoclonal anti-Thy-1,2 antibodies, cyclosporine A, and lentil lectin in mice.
    Hilgert I; Stoyanov S; Kristofová H
    Transplant Proc; 1987 Feb; 19(1 Pt 2):1269. PubMed ID: 3274316
    [No Abstract]   [Full Text] [Related]  

  • 3. Determination of the functional status of alloreactive T cells by interferon-gamma kinetics.
    Kwun J; Knechtle SJ; Hu H
    Transplantation; 2006 Feb; 81(4):590-8. PubMed ID: 16495808
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vivo effects of cyclosporine in the generation and expression of effector cell function.
    Schiltknecht E; Ada GL
    Transplant Proc; 1986 Apr; 18(2):357-9. PubMed ID: 3485846
    [No Abstract]   [Full Text] [Related]  

  • 5. Clinical and experimental studies with cyclosporine in renal transplantation.
    Kahan BD; van Buren CT; Flechner SM; Jarowenko M; Yasumura T; Rogers AJ; Yoshimura N; LeGrue S; Drath D; Kerman RH
    Surgery; 1985 Feb; 97(2):125-40. PubMed ID: 3881837
    [No Abstract]   [Full Text] [Related]  

  • 6. Toward understanding the mechanism of ciclosporin (cyclosporine) immunosuppression.
    Lorber MI
    Year Immunol; 1988; 3():291-302. PubMed ID: 3327316
    [No Abstract]   [Full Text] [Related]  

  • 7. Comparison of the pharmacological profiles of cyclosporine, (Nva2)-cyclosporine and (Val2)dihydro-cyclosporine.
    Hiestand PC; Gunn HC; Gale JM; Ryffel B; Borel JF
    Immunology; 1985 Jun; 55(2):249-55. PubMed ID: 3891595
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effect of cyclosporine on the induction of unresponsiveness in antilymphocyte serum-treated, marrow-injected mice.
    Wood ML; Gottschalk R; Monaco AP
    Transplantation; 1988 Sep; 46(3):449-51. PubMed ID: 3047934
    [No Abstract]   [Full Text] [Related]  

  • 9. Analysis of T cell function using cyclosporine: graft rejection by T cells involves lymphokine release.
    Hodgkin PD; Agostino M; Lafferty KJ
    Transplant Proc; 1985 Apr; 17(2):1644-5. PubMed ID: 3920797
    [No Abstract]   [Full Text] [Related]  

  • 10. Blockade of T-dependent major histocompatibility complex induction: a key immunosuppressive effect of cyclosporine.
    Autenried P; Halloran PF
    Transplant Proc; 1987 Feb; 19(1 Pt 2):1184-5. PubMed ID: 3152623
    [No Abstract]   [Full Text] [Related]  

  • 11. T-lymphocyte and cytokine-directed strategies for inhibiting skin allograft rejection in mice.
    Vossen AC; Tibbe GJ; Benner R; Savelkoul HF
    Transplant Proc; 1995 Feb; 27(1):380-2. PubMed ID: 7879028
    [No Abstract]   [Full Text] [Related]  

  • 12. Effects of in vivo administration of anti-T3 monoclonal antibody on T cell function in mice. I. Immunosuppression of transplantation responses.
    Hirsch R; Eckhaus M; Auchincloss H; Sachs DH; Bluestone JA
    J Immunol; 1988 Jun; 140(11):3766-72. PubMed ID: 3286764
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of kidney, composite tissue, and skin allograft survival in rats prolonged by donor blood and concomitant limited cyclosporine.
    Hewitt CW; Black KS; Stenger JA; Go C; Achauer BM; Martin DC
    Transplant Proc; 1988 Jun; 20(3 Suppl 3):1110-3. PubMed ID: 3291221
    [No Abstract]   [Full Text] [Related]  

  • 14. Prolonged allograft survival in xenotransfused mice after graft and/or donor pretreatment with cyclosporine and/or concanavalin A.
    Sharma V; Toledo-Pereyra LH
    Transplantation; 1987 Apr; 43(4):587-9. PubMed ID: 3554648
    [No Abstract]   [Full Text] [Related]  

  • 15. Cyclosporine and unresponsiveness to allografts induced by polyclonal antilymphocyte serum and donor-specific bone marrow.
    Monaco AP; Wood ML; Maki T; Hartner W; De Fazio S; Gozzo JJ
    Transplant Proc; 1988 Jun; 20(3 Suppl 3):36-48. PubMed ID: 2968700
    [No Abstract]   [Full Text] [Related]  

  • 16. Alloantigen-induced, T-cell-dependent production of nitric oxide by macrophages infiltrating skin allografts in mice.
    Krulová M; Zajícová A; Fric J; Holán V
    Transpl Int; 2002 Mar; 15(2-3):108-16. PubMed ID: 11935167
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunomodulation by an inhibitor of S-adenosyl-L-homocysteine hydrolase: inhibition of in vitro and in vivo allogeneic responses.
    Wolos JA; Frondorf KA; Babcock GF; Stripp SA; Bowlin TL
    Cell Immunol; 1993 Jul; 149(2):402-8. PubMed ID: 8330316
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hematopoietic stem cell chimerism: relationships between degree of chimerism, T cell clonal deletion, and graft survival.
    Taniguchi H; Jinzenji Y; Fukao K; Nakauchi H
    Transplant Proc; 1994 Aug; 26(4):1966-8. PubMed ID: 8066636
    [No Abstract]   [Full Text] [Related]  

  • 19. Recruitment of effector T lymphocytes by initiator T lymphocytes: application for specific immunosuppression.
    Cohen IR; Belldegrün A; Ben-Nun A; Hazan R
    Transplant Proc; 1981 Mar; 13(1 Pt 1):623-5. PubMed ID: 7022903
    [No Abstract]   [Full Text] [Related]  

  • 20. [Cyclosporin A].
    Thiele HG
    Immun Infekt; 1984 Jun; 12(3):157-62. PubMed ID: 6398798
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.